Resistant Gram-positive Bacteria Research Articles

The transmembrane segment of TagH is required for wall teichoic acid transport under heat stress in Bacillus subtilis.

Wall teichoic acids (WTAs) are anionic polymers that are covalently linked to peptidoglycan and play important roles in cell shape determination, cell division, autolysis, pathogenesis and antibiotic resistance in Gram-positive bacteria. In Bacillus subtilis, WTA is synthesized in the cytoplasm and translocated by an ABC transporter, TagGH. In this study, we found that the transmembrane segment of TagH is required for WTA transport under high temperatures. Cells expressing TagH302-FL (a construct fused to the 6×FLAG tag after the transmembrane segment, which lacks the C-terminal extracellular domain) grew normally at high temperatures, similar to those expressing the full-length TagH-FL fusion. In contrast, cells expressing TagH275-FL, which lacks both the transmembrane segment and the extracellular domain, exhibited a temperature-sensitive phenotype at temperatures above 49 °C and a growth defect at 50 °C. Interestingly, this growth defect was dissolved by an additional incubation at 37 °C. A similar temperature-sensitive phenotype was observed in cells expressing an N-terminal 6×FLAG tag fusion of TagH275. Immunofluorescence microscopy (IFM) indicated that TagG and TagH are localized on the cytoplasmic membrane in a patch-like manner. In addition, the C-terminal-truncated forms, TagH275-FL and TagH302-FL, were localized in similar patch-like patterns at 37 °C; only foci for TagH275-FL were remarkably reduced at high temperatures. Moreover, cell surface decoration with WTA was considerably reduced in cells harbouring TagH275-FL at high temperature, supporting the results of IFM observation. These results suggest that the transmembrane segment of TagH plays an important role in WTA export at high temperatures.

Long-term antibacterial efficacy of disinfectants based on benzalkonium chloride and sodium hypochlorite tested on surfaces against resistant gram-positive bacteria

The long-term antibacterial activity of disinfectant products based on benzalkonium chloride and sodium hypochlorite on surfaces was evaluated for prevention of bacterial adhesion. To this end, the European standard EN 13697, which determines the antibacterial activity of disinfectant formulations on bacteria, was adapted. As a prior step, the initial antibacterial activity (≥4 log10) was determined and after 24 h the long-term efficacy (≥3 log10) of each disinfectant product. Gram-positive bacteria belonging to the genera Staphylococci and Enterococci are able to survive in adverse conditions and have been involved in the increasing of bacterial resistance to different antimicrobials. In this study, Staphylococcus aureus and Enterococcus hirae were selected as ‘indicator organisms’ for the presence of bacterial contamination. The results showed that all the disinfectant products based on benzalkonium chloride and sodium hypochlorite had an initial antibacterial activity of up to 4 log10. After 24 h, the benzalkonium chloride based products demonstrated long-term antibacterial efficacy for both bacterial strains. Sodium hypochlorite as a sole compound at 4.0% did not demonstrate long-term efficacy, but when it was formulated with sodium hydroxide, benzalkonium chloride, fatty alcohol ethoxylate and amine oxide, it was effective. The bactericidal test developed in this study fulfills the purpose of evaluating the long-term antibacterial efficacy of disinfectant products on surfaces.

Chemical composition, antioxidant and antimicrobial activity of phenolic compounds extracted from wine industry by-products

Winery by-products are a rich source of polyphenols, which have proven to have several beneficial biological properties, such as, antioxidant and antimicrobial activities. Therefore, this study aimed the extraction of polyphenols from winery by-products of two Portuguese red grape varieties, Touriga Nacional and Preto Martinho, and evaluate their phenolic profile, antioxidant properties and antimicrobial activity against antibiotic resistant bacteria. The polyphenols were extracted from the grapes' skins, seeds and stems. Extracts were analysed for total phenolic, anthocyanin and tannin contents, and the polyphenol profile was determined by High Performance Liquid Chromatography. The antioxidant activity of the extracts was determined by ABTS+ and DPPH methods. Antimicrobial susceptibility assay was performed using Kirby-Bauer disc diffusion method. Preto Martinho variety presented a higher polyphenolic content than Touriga Nacional. Malvidin 3-O-glucoside was the most abundant compound found in the skins extracts in both varieties. The main phenolic compound found in the seeds and stems extracts was catechin. From the several flavonols quantified, rutin was the most abundant. For both varieties, the seeds extracts showed the highest antioxidant and antimicrobial properties, followed by the stems extracts. The extracts showed antibacterial activity against all tested strains except on gram-negative bacteria Salmonella enteritidis, Escherichia coli and Pseudomonas aeruginosa. These results show that, natural products, such as polyphenols, may represent a source for the development of novel antimicrobials to combat gram-positive resistant bacteria and possibly be used as natural food preservatives. However, they were not effective against gram-negative resistant bacteria which shows that polyphenols, alone, might not substitute antibiotics.

In Vitro Antimicrobial Activities of 6-Substituted-3(2H)- pyridazinone-2-acetyl-2- (substituted/nonsubstitutedbenzal/ acetophenone) Hydrazone Derivatives

Abstract Aim: In vitro antibacterial activity of 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(substituted/nonsubstitutedbenzal/ acetophenone) hydrazone derivatives were tested in common species causing hospital-acquired infections. Material and Method: Antimicrobial activities of the compounds were performed by determining minimum inhibitory concentration (MIC) value against four Gram-positive, five Gram-negative and four Candida species fungi. Modified serial microdilution method was carried out. Reference strains of American Type Culture Collection (ATCC) were used. Results: In general, eleven compounds exhibited considerable activity. Comparatively, compound 3 exhibited strong activity against Enterobacter hormaechei and 5, 11 were the most active against Acinetobacter baumannii at 31.25 μg/mL. Compounds 1,2,3,4,8 and 10 were found to be as active as positive control ampicillin trihidrate against Stenotrophomonas maltophilia. On the other hand, compounds 1,2,3,4,7,8,9,10 and 11 showed strong antifungal activitiy as much as fluconazole against Candida tropicalis. Compound 1 was mostly active against Candida albicans, Candida glabrata, Candida parapsilosis and Candida tropicalis. It was also revealed that the antifungal activity of compounds 1, 6, 7, 8 and 9 were higher than the others. Compound 1 and 8 exhibited the best activity against Candida glabrata and Candida parapsilosis respectively. Conclusions: All tested compounds showed better activity against Gram-negative bacteria and yeast than Gram-positive bacteria. These compounds may be considered as alternative antimicrobial agents in the treatment of multiple drug resistant Gram-negative, Gram-positive bacteria and fungal pathogens. Especially, we suggested that Compound 1 and 8 might be a promising candidate of new antifungal agents

Synthesis, characterization, antiproliferative, and antimicrobial activity of osmium(II) half-sandwich complexes

New osmium(II)-arene complexes [(η6-C6H6)OsCl(C5H4N-2-CH=N-C6H5X)](PF6) (X = p-flouro (1), p-chloro (2), p-methyl (3)) were synthesized by reaction of the corresponding bidentate N,N′-ligands with the osmium-arene precursor [(η6-C6H6)Os(μ-Cl)Cl]2 in a 2:1 ratio. These complexes were characterized by UV–Vis, IR, 1H, 13C NMR spectroscopy, and elemental analysis and, for compound 1, a single crystal X-ray structure was also obtained. The complexes were investigated for antiproliferative activity in vitro against MCF-7 (human breast adenocarcinoma), Caco-2 (human epithelial colorectal adenocarcinoma), and HepG2 (human hepatocellular carcinoma) tumor cell lines. To test their selectivity, the non-tumor HEK293 (human embryonic kidney) cell line was used. The compounds were selective toward the tumor cell lines when compared to the known anticancer drug 5-fluorouracil which displayed low selectivity. The compounds were substantially more active against Caco-2 than 5-fluorouracil. They also showed moderate activity against the other two tumor cell lines. In addition, the antimicrobial activity of complex 2 was explored against a panel of antimicrobial-susceptible and -resistant Gram-negative and Gram-positive bacteria. Complex 2 showed anti-mycobacterial activity against Mycobacterium smegmatis and bactericidal activity against drug-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus ATCC 43300.

Natural Products And Traditional Medicines For The Treatment Of Multidrug Resistant Bacteria

Multidrug resistant microorganisms (MDROs) have been responsible for numerous outbreaks of infectious epidemics, and pose a serious threat to global health. The lack of effective therapies for these MDROs, coupled with a reduced number of antimicrobial drugs in the pharmaceutical pipeline to treat these infections indicates an urgent need for research in this area. Of the resistant Gram-positive bacteria, methicillin-resistant Staphylococcus aureus (MRSA), multidrug-resistant Pseudomonas aeruginosa and multidrug-resistant tuberculosis (MDR-TB) continue to be the most problematic, but more recently there has been increasing reports of vancomycin-resistant Staphylococcus aureus (VRSA) infections. For highly-resistant Gram-negative bacteria, Vancomycin-resistant Enterococci (VRE), multidrug-resistant carbapenemase-producing Klebsiella pneumoniae and MDR-Acinetobacter baumannii are important as these bacteria are often only susceptible to older antimicrobial agents, such as the polymyxins that have a higher adverse event profile. Thus, there is an urgent need for new antibiotics and combinations of drugs to treat these emerging MDR bacteria. The lack of interest by pharmaceutical companies in the research and development of new antibiotics has increased research in the field of natural products. An increasing body of scientific evidence suggests that specific marine, fungal and medicinal plant extracts, as well as traditional medicine formulas and purified natural products are active against specific MDR-bacteria, and thus could be further investigated and possibly developed as clinical agents. This review focuses on recently published data for natural products active against MDR bacteria and evaluates some of the recent published in vitro data.

C8-Linked Pyrrolobenzodiazepine Monomers with Inverted Building Blocks Show Selective Activity against Multidrug Resistant Gram-Positive Bacteria.

Antimicrobial resistance has become a major global concern. Development of novel antimicrobial agents for the treatment of infections caused by multidrug resistant (MDR) pathogens is an urgent priority. Pyrrolobenzodiazepines (PBDs) are a promising class of antibacterial agents initially discovered and isolated from natural sources. Recently, C8-linked PBD biaryl conjugates have been shown to be active against some MDR Gram-positive strains. To explore the role of building block orientations on antibacterial activity and obtain structure activity relationship (SAR) information, four novel structures were synthesized in which the building blocks of previously reported compounds were inverted, and their antibacterial activity was studied. The compounds showed minimum inhibitory concentrations (MICs) in the range of 0.125-32 μg/mL against MDR Gram-positive strains with a bactericidal mode of action. The results showed that a single inversion of amide bonds reduces the activity while the double inversion restores the activity against MDR pathogens. All inverted compounds did not stabilize DNA and lacked eukaryotic toxicity. The compounds inhibit DNA gyrase in vitro, and the most potent compound was equally active against both wild-type and mutant DNA gyrase in a biochemical assay. The observed activity of the compounds against methicillin resistant S.aureus (MRSA) strains with equivalent gyrase mutations is consistent with gyrase inhibition being the mechanism of action in vivo, although this has not been definitively confirmed in whole cells. This conclusion is supported by a molecular modeling study showing interaction of the compounds with wild-type and mutant gyrases. This study provides important SAR information about this new class of antibacterial agents.

Synthesis, anti-bacterial and anti-protozoal activities of amidinobenzimidazole derivatives and their interactions with DNA and RNA

Amidinobenzimidazole derivatives connected to 1-aryl-substituted 1,2,3-triazole through phenoxymethylene linkers 7a–7e, 8a–8e, and 9a–9e were designed and synthesised with the aim of evaluating their anti-bacterial and anti-trypanosomal activities and DNA/RNA binding affinity. Results from anti-bacterial evaluations of antibiotic-resistant pathogenic bacteria revealed that both o-chlorophenyl-1,2,3-triazole and N-isopropylamidine moieties in 8c led to strong inhibitory activity against resistant Gram-positive bacteria, particularly the MRSA strain. Furthermore, the non-substituted amidine and phenyl ring in 7a induced a marked anti-bacterial effect, with potency against ESBL-producing Gram-negative E. coli better than those of the antibiotics ceftazidime and ciprofloxacin. UV–Vis and CD spectroscopy, as well as thermal denaturation assays, indicated that compounds 7a and 8c showed also binding affinities towards ctDNA. Anti-trypanosomal evaluations showed that the p-methoxyphenyl-1,2,3-triazole moiety in 7b and 9b enhanced inhibitory activity against T. brucei, with 8b being more potent than nifurtimox, and having minimal toxicity towards mammalian cells.

What Is Old Is New Again: Delafloxacin, a Modern Fluoroquinolone.

Delafloxacin is a new fluoroquinolone antimicrobial approved for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in adults using dosage regimens of 300mg intravenously every 12hours, 450mg orally every 12hours, or switching from intravenous to oral regimens for a 5- to 14-day treatment duration. Dosage adjustments in patients with severe renal dysfunction (estimated glomerular filtration rate [eGFR]=15-29ml/min/1.73m2 ) are not required for oral doses but should be decreased to 200mg intravenously every 12hours in patients requiring parenteral therapy. Due to insufficient data, use of delafloxacin is not recommended for patients on hemodialysis or with end-stage renal disease (eGFR <15ml/min/1.73m2 ). Delafloxacin works through inhibition of DNA gyrase (topoisomerase II) and topoisomerase IV, which are essential enzymes for bacterial DNA transcription, replication, repair, and recombination and exhibits bactericidal activity against gram-positive and gram-negative organisms through a concentration-dependent matter. Delafloxacin has a very broad spectrum of activity against atypical, anaerobic, and resistant gram-negative and gram-positive bacteria, including methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. During phase 3 trials, the most common side effects associated with delafloxacin were gastrointestinal (nausea, diarrhea). Unlike other fluoroquinolones, there does not seem to be a risk of QTc prolongation or phototoxicity with delafloxacin. The availability of both parenteral and oral formulations for delafloxacin distinguishes it from many of the currently available agents approved for ABSSSIs. Phase 3 studies for the treatment of respiratory infections are currently under way, and future results of these studies will further help delineate the role of delafloxacin.

Daptomycin.

Daptomycin is a cyclic lipopeptide antibiotic used for the treatment of Gram-positive infections including complicated skin and skin structure infections, right-sided infective endocarditis, bacteraemia, meningitis, sepsis and urinary tract infections. Daptomycin has distinct mechanisms of action, disrupting multiple aspects of cell membrane function and inhibiting protein, DNA and RNA synthesis. Although daptomycin resistance in Gram-positive bacteria is uncommon, there are increasing reports of daptomycin resistance in Staphylococcus aureus, Enterococcus faecium and Enterococcus faecalis. Such resistance is seen largely in the context of prolonged treatment courses and infections with high bacterial burdens, but may occur in the absence of prior daptomycin exposure. Furthermore, use of inadequate treatment regimens, irregular drug supply and poor drug quality have also been recognized as other important risk factors for emergence of daptomycin-resistant strains. Antimicrobial susceptibility testing of Gram-positive bacteria, communication between clinicians and laboratories, establishment of internet-based reporting systems, development of better and more rapid diagnostic methods and continuous monitoring of drug resistance are urgent priorities.

Review of Antibiotic Resistance in the Indian Ocean Commission: A Human and Animal Health Issue.

Antimicrobial resistance (AMR) is a major threat to human, animal health, and environment worldwide. For human, transmission occurred through a variety of routes both in health-care settings and community. In animals, AMR was reported in livestock, pets, and wildlife; transmission of AMR can be zoonotic with the probably most important route being foodborne transmission. The Indian Ocean Commission (IOC), composed of Comoros, Madagascar, Mauritius, Reunion (France), and Seychelles recognized the surveillance of AMR in both animal and human as a main public health priority for the region. Mayotte, French overseas territory, located in Comoros archipelago, was also included in this review. This review summarized our best epidemiological knowledge regarding AMR in Indian Ocean. We documented the prevalence, and phenotypic and genotypic profiles of prone to resistance Gram-positive and Gram-negative bacteria both in animals and humans. Our review clearly pointed out extended-spectrum β-lactamase and carbapenemase-producing Enterobacteriaceae as main human and animal health issue in IOC. However, publications on AMR are scarce, particularly in Comoros, Mayotte, and Seychelles. Thus, research and surveillance priorities were recommended (i) estimating the volume of antimicrobial drugs used in livestock and human medicine in the different territories [mainly third generation cephalosporin (3GC)]; (ii) developing a “One Health” surveillance approach with epidemiological indicators as zoonotic foodborne pathogen (i.e., couple Escherichia coli resistance to 3GC/carbapenems); (iii) screening travelers with a history of hospitalization and consumption of antibiotic drug returning from at risk areas (e.g., mcr-1 transmission with China or hajj pilgrims) allowing an early warning detection of the emergence for quick control measures implementation in IOC.

Synthesis, Properties, and Mechanism of Action of New Generation of Polycyclic Glycopeptide Antibiotics.

The increased resistance of glycopeptide based antibiotics has become a serious problem for the chemotherapy of infections triggered by resistant Gram-positive bacteria. This has motivated the urgent sincere efforts to develop potent glycopeptide-based antibiotics in both academy and industry research laboratories. Understanding of the mechanism of action of natural and modified glycopeptides is considered as the basis for the rational design of compounds with valuable properties to achieve the fundamental results. Several hydrophobic glycopeptide analogues active against resistant strains were developed during the last two decades. Three drugs, namely, oritavancin, telavancin and dalbavancin were approved by FDA in 2013-2014. It was found that hydrophobic derivatives act through different mechanisms without binding with the modified target of resistant bacteria. Types: Different types of chemical modifications led to several glycopeptide analogues active against Gram-negative bacteria as advocated by in vitro studies or demonstrating potent antiviral activity in the cell models. A new class of glycopeptide antibiotics with potent activity against sensitive and resistant bacterial strains has been recently reported with the aim to overcome the resistance, however, there are a lot of obscure problems in the complete understanding of their mechanisms of actions. In this review, we summarized the achievements of synthetic methods devoted to the construction of new polycyclic glycopeptide antibiotics and described the studies related to their mechanism of actions.

Rapid Phenotypic Detection of Microbial Resistance in Gram-Positive Bacteria by a Real-Time Laser Scattering Method.

We developed a methodology for antimicrobial susceptibility testing (AST) based on the BacterioScanTM216R laser scattering technology, using methicillin resistance in Staphylococcus aureus and vancomycin resistance in enterococci as exemplar for important resistance phenotypes. Fifty methicillin-resistant (MRSA) and 50 methicillin-susceptible (MSSA) S. aureus, as well as 50 vancomycin-resistant enterococci (VRE) and 50 vancomycin-susceptible enterococci (VSE) isolates were used for the study. Optimal test conditions were derived by investigating the effects of inoculum size, medium, incubation temperature and broth filtration. We proposed four different statistical approaches for rapid discrimination between resistant and susceptible bacteria. The statistical approach based on raw measurements of bacterial concentrations delivered sensitivity of 100% and specificity of 94% for discrimination between MRSA and MSSA already after 3 hours of incubation. Categorical agreement of ≥90% was achieved after 140 min with this approach. Differentiation between VRE and VSE was possible with 98% sensitivity and 92% specificity after 3 hours, using a sophisticated statistical approach based on concentration slopes derived from the raw concentration measurements. This approach provided categorical agreement of ≥90% after 165 min. The sensitivity and specificity estimates were confirmed by leave-one-out cross validation. In conclusion, the phenotypic AST methods developed in this study are promising for rapid detection of MRSA and VRE. The development and application of this technology would allow early detection of the resistant pathogens, thus facilitating swift change to the targeted antimicrobial treatment as well as timely initiation of appropriate infection control measures. Further studies are warranted to validate this approach for the detection of other resistance phenotypes, including direct testing from clinical specimens.

Antibacterial Compounds from Marine Bacteria, 2010-2015.

This review summarizes the reports on antibacterial compounds that have been obtained from marine-derived bacteria during the period 2010-2015. Over 50 active compounds were isolated during this period, most of which (69%) were obtained from Actinobacteria. Several compounds were already known, such as etamycin A (11) and nosiheptide (65), and new experiments with them showed some previously undetected antibacterial activities, highlighting the fact that known natural products may be an important source of new antibacterial leads. New broad-spectrum antibacterial compounds were reported with activity against antibiotic resistant Gram-positive and Gram-negative bacteria. Anthracimycin (33), kocurin (66), gageotetrins A-C (72-74), and gageomacrolactins 1-3 (86-88) are examples of compounds that display promising properties and could be leads to new antibiotics. A number of microbes produced mixtures of metabolites sharing similar chemical scaffolds, and structure-activity relationships are discussed.

Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.

Antimicrobial resistance in gram-positive bacteria remains a challenge in infectious diseases. The mission of the Gram-Positive Committee of the Antibacterial Resistance Leadership Group (ARLG) is to advance knowledge in the prevention, management, and treatment of these challenging infections to improve patient outcomes. Our committee has prioritized projects involving methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) due to the scope of the medical threat posed by these pathogens. Approved ARLG projects involving gram-positive pathogens include (1) a pharmacokinetics/pharmacodynamics study to evaluate the impact of vancomycin dosing on patient outcome in MRSA bloodstream infection (BSI); (2) defining, testing, and validating innovative assessments of patient outcomes for clinical trials of MRSA-BSI; (3) testing new strategies for "step-down" antibiotic therapy for MRSA-BSI; (4) management of staphylococcal BSIs in neonatal intensive care units; and (5) defining the impact of VRE bacteremia and daptomycin susceptibility on patient outcomes. This article outlines accomplishments, priorities, and challenges for research of infections caused by gram-positive organisms.

Antimicrobial AApeptides.

Antibiotic resistance is one of the biggest public concerns in the 21st century. Host-defense peptides (HDPs) can potentially mitigate the problem through bacterial membrane disruption; however, they suffer from moderate activity and low stability. We recently developed a new class of peptidomimetics termed "AApeptides". This class of peptidomimetics can mimic the mechanism of action of HDPs, and effectively arrest the growth of multidrug resistant Gram-positive and Gram-negative bacteria. As they are built on unnatural backbone, they are resistant to proteolytic degradation. In this review, we summarize the development of this class of antimicrobial peptidomimetics, and discuss the future perspective on how they can move forward on combating antibiotic resistance.

Interventions to improve antibiotic prescribing practices for hospital inpatients.

Interventions to improve antibiotic prescribing practices for hospital inpatients.

Recent Developments in Accelerated Antibacterial Inactivation on 2D Cu-Titania Surfaces under Indoor Visible Light

This review focuses on Cu/TiO2 sequentially sputtered and Cu-TiO2 co-sputtered catalytic/photocatalytic surfaces that lead to bacterial inactivation, discussing their stability, synthesis, adhesion, and antibacterial kinetics. The intervention of TiO2, Cu, and the synergic effect of Cu and TiO2 on films prepared by a colloidal sol-gel method leading to bacterial inactivation is reviewed. Processes in aerobic and anaerobic media leading to bacterial loss of viability in multidrug resistant (MDR) pathogens, Gram-negative, and Gram-positive bacteria are described. Insight is provided for the interfacial charge transfer mechanism under solar irradiation occurring between TiO2 and Cu. Surface properties of 2D TiO2/Cu and TiO2-Cu films are correlated with the bacterial inactivation kinetics in dark and under light conditions. The intervention of these antibacterial sputtered surfaces in health-care facilities, leading to Methicillin-resistant Staphylococcus Aureus (MRSA)-isolates inactivation, is described in dark and under actinic light conditions. The synergic intervention of the Cu and TiO2 films leading to bacterial inactivation prepared by direct current magnetron sputtering (DCMS), pulsed direct current magnetron sputtering (DCMSP), and high power impulse magnetron sputtering (HIPIMS) is reported in a detailed manner.

Antibacterial activity of Limonium brasiliense (Baicuru) against multidrug-resistant bacteria using a statistical mixture design

Ethnopharmacological relevanceLimonium brasiliense (Boiss.) Kuntze (Plumbaginaceae) is commonly known as “baicuru” or “guaicuru” and preparations of its dried rhizomes have been popularly used in the treatment of premenstrual syndrome and menstrual disorder, and as an antiseptic in genito-urinary infections. This study evaluated the potential antibacterial activity of rhizome extracts against multidrug–resistant bacterial strains using statistical mixture design. Materials and methodsThe statistical design of four components (water, methanol, acetone, and ethanol) produced 15 different extracts and also a confirmatory experiment, which was performed using water:acetone (3:7, v/v). The crude extracts and their ethyl-acetate fractions were tested against vancomycin–resistant Enterococcus faecium (VREfm), methicillin–resistant Staphylococcus aureus (MRSA) and Klebsiella pneumoniae carbapenemase (KPC)–producing K. pneumoniae, all of which have been implicated in hospital and community–acquired infections. The dry residue, total polyphenol, gallocatechin and epigallocatechin contents of the extracts were also tested and statistical analysis was applied in order to define the fit models to predict the result of each parameter for any mixture of components. The principal component and hierarchical clustering analyses (PCA and HCA) of chromatographic data, as well as mass spectrometry (MS) analysis were performanced to determine the main compounds present in the extracts. ResultsThe Gram-positive bacteria were susceptible to inhibition of bacterial growth, in special the ethyl-acetate fraction of ternary extracts from water:acetone:ethanol and methanol:acetone:ethanol against, respectively, VREfm (MIC=19µg/mL) and MRSA (MIC=39µg/mL). On the other hand, moderate activity of the ethyl-acetate fractions from primary (except water), secondary and ternary extracts (MIC=625µg/mL) was noted against KPC. The quadratic and special cubic models were significant for polyphenols and gallocatechin contents, respectively. Fit models to dry residue and epigallocatechin contents were not possible. PCA and HCA of the chromatographic fingerprints were disturbed by displacement retention time of some peaks, but the ultraviolet spectra indicated the homogeneous presence of flavan-3-ols characteristic of tannins. The MS confirmed the presence of gallic acid, gallocatechin, and epigallocatechin in extracts, and suggested the presence of monomers and dimers of B- and A-type prodelphinidins gallate, as well as a methyl gallate. ConclusionOur results showed the antibacterial potential of L. brasiliense extracts against multidrug–resistant Gram-positive bacteria, such as VREfm and MRSA. The statistical design was a important tool to evaluate the biological activity by optimized form. The presence of some phenolic compounds was also demonstrated in extracts.

Chemical Composition and Bactericidal Activities of the Leaf Essential Oil of Eucalyptus maculata Hook

This study examined the phytochemicals and medicinal potentials of the leaf essential oil of E. maculata from Nigeria. The essential oil was extracted by hydro-distillation technique and was analysed for various chemical composition using GC-MS. The essential oil was also screened for its antimicrobial activities against multi-drug resistant gram-positive and gram-negative bacteria using the agar well diffusion method. The GC-MS analysis revealed that s-citronellol (18.5%), s-pinene (9.4%), 2,6-dimethyl-2,6-octadiene (8.3%), a-pinene (7.1%), 2,6-dimethyl-1,3,5,7- octatetraene (6.7%), and citronellyl acetate (6.0%) were the major compounds in the leaf essential oil. The essential oil exhibited strong antibacterial activities against most of the tested bacteria, with diameters of inhibition zones ranging from 15.0-30.0 mm. The leaf essential oil of E. maculata is a possible alternative antibiotic drug for treatment of disease caused by multi-drug resistant bacteria.